洁特生物(688026.SH)业绩快报:2020年度净利润升96.62%至1.3亿元
格隆汇 2 月 26日丨洁特生物(688026.SH)披露2020年度业绩快报,实现营业收入5.04亿元,同比增长103.55%;营业利润1.53亿元,同比增长100.62%;利润总额1.53亿元,同比增长100.16%;归属于母公司所有者的净利润1.30亿元,同比增长96.62%;归属于母公司所有者的扣除非经常性损益的净利润1.17亿元,同比增长112.35%;基本每股收益1.34元。
营业收入同比增长主要系公司生物实验室一次性塑料耗材和防护类产品销售增加所致。利润总额、归属于母公司所有者的净利润、归属于母公司所有者的扣除非经常性损益的净利润同比增长主要系公司营业收入的增长所致。
鉴于新冠肺炎疫情的爆发,上半年与防疫相关产品的需求急剧增加,公司全资子公司的防护类产品业务全年实现了约2亿元左右的销售收入(其中:1-9月份实现1.83亿元),较上年同期的18.38万元相比出现了大幅增长。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.